IT enters its May 5 Q1 earnings call with short sellers more convicted than at any point in recent months — and options traders adding a fresh layer of caution on top.
Short interest has accelerated sharply this week. SI % FF climbed to nearly 13.9% of the free float, up from around 11.5% a week ago — a move of roughly 20% in just five sessions. That is the steepest single-week build since at least mid-March, and it comes after short positions had actually drifted lower through most of April. The ORTEX short score has risen with it, reaching 61.1, its highest of the tracked period. Availability has tightened to its narrowest level of the past year, suggesting demand for borrows is running harder than supply can comfortably accommodate. Cost to borrow remains subdued at 0.43%, so the borrow market is not yet punishing new short entries — but the rapid addition of shares short in the final days before earnings is a clear directional signal.
Options positioning has turned sharply more defensive. The put/call ratio jumped to 0.68 on April 29, more than three standard deviations above its 20-day mean of 0.51 — the most defensive reading on record relative to recent history, and a meaningful break from the sub-0.50 levels that persisted for most of the prior six weeks. The setup looks like a deliberate hedge around the earnings event, rather than a structural bear view. The stock has given back 4.4% on the week and 3.3% over the past month to close at $150.23. That leaves it down more than 41% year to date — context that matters when reading the scale of protection demand.
The Street has been cutting targets aggressively since February's results. Goldman Sachs, maintaining its Neutral rating, slashed its target to $171 from $220 the day after this note's data was captured — the most recent move from a bellwether firm, and one that reflects the scale of the reset the sell side has had to absorb. Barclays, Wells Fargo, and UBS all trimmed targets in March and April with no rating changes. The consensus remains a hold across 13 analysts, with just three buys. The mean target of $173 represents about 15% upside to the current price, but that figure carries significant downward momentum; it was roughly $270 six months ago. The bear case centres on flat EBITDA margins projected around 23.5%, a potential deceleration in the Insights segment, and the risk that GenAI tools disintermediate demand for Gartner's advisory products. Bulls point to the segment's 82% revenue share and a long track record of contribution margin expansion. The EV/EBITDA multiple is holding near 7.7x — well compressed relative to where the stock was trading before the February selloff.
That February print is the key reference point for positioning. The stock fell 22% on the day and another 21% over the following five sessions — the sharpest single-earnings reaction in the available history. Every subsequent analyst target revision was made in the context of that move, and short sellers have been rebuilding positions around it ever since. Peers have also had a difficult week: ACN fell 8.6%, CTSH slid 8.8%, and EPAM dropped 13.6%, suggesting the IT services sector broadly is facing macro headwinds that amplify any stock-specific disappointment.
The May 5 print is the event the whole positioning picture is pointed at. Whether Gartner can demonstrate that Insights demand is holding, and offer any credible guidance on the GenAI disruption risk, will determine whether the near-14% short position continues to grow or begins to unwind.
See the live data behind this article on ORTEX.
Open IT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
